Quantum Generative Models for Small Molecule Drug Discovery
Existing drug discovery pipelines take 5-10 years and cost billions of dollars. Computational approaches aim to sample from regions of the whole molecular and solid-state compounds called chemical space which could be on the order of 1060 . Deep generative models can model the underlying probability distribution of both the physical structures and property of drugs and relate them nonlinearly. By exploiting patterns in massive datasets, these models can distill salient features that characterize the molecules. Generative Adversarial Networks (GANs) discover drug candidates by generating molecular structures that obey chemical and physical properties and show affinity towards binding with the receptor for a target disease. However, classical GANs cannot explore certain regions of the chemical space and suffer from curse-of-dimensionality. A full quantum GAN may require more than 90 qubits even to generate QM9-like small molecules. We propose a qubit-efficient quantum GAN with a hybrid generator (QGAN-HG) to learn richer representation of molecules via searching exponentially large chemical space with few qubits more efficiently than classical GAN. The QGANHG model is composed of a hybrid quantum generator that supports various number of qubits and quantum circuit layers, and, a classical discriminator. QGAN-HG with only 14.93% retained parameters can learn molecular distribution as efficiently as classical counterpart. The QGAN-HG variation with patched circuits considerably accelerates our standard QGANHG training process and avoids potential gradient vanishing issue of deep neural networks. Code is available on GitHub https://github.com/jundeli/quantum-gan.
Code (1)
Tasks
Drug DiscoverySimilar Papers 제목 키워드 기반
Drug Discovery Approaches using Quantum Machine Learning
Traditional drug discovery pipeline takes several years and cost billions of dollars. Deep generative and predictive models are widely adopted to assist in drug development. Classical machines cannot efficiently produce …
BIG-bench Machine LearningDrug DiscoveryGenerative Adversarial NetworkQuantum Machine LearningQuantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS
The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development…
Drug DiscoveryHybrid quantum-classical machine learning for generative chemistry and drug design
Deep generative chemistry models emerge as powerful tools to expedite drug discovery. However, the immense size and complexity of the structural space of all possible drug-like molecules pose significant obstacles, which…
Drug DesignDrug DiscoveryScalable Variational Quantum Circuits for Autoencoder-based Drug Discovery
The de novo design of drug molecules is recognized as a time-consuming and costly process, and computational approaches have been applied in each stage of the drug discovery pipeline. Variational autoencoder is one of th…
Drug DiscoveryQuantum Machine LearningRepresentation LearningHybrid quantum cycle generative adversarial network for small molecule generation
The drug design process currently requires considerable time and resources to develop each new compound that enters the market. This work develops an application of hybrid quantum generative models based on the integrati…
DiversityDrug DesignDrug DiscoveryGenerative Adversarial Network+1